Novo Nordisk CEO: "We are very encouraged by growth momentum"

A theme of Novo Nordisk’s capital markets day on Thursday is how to stay on the current growth track in the future, says CEO Lars Fruergaard Jørgensen.
Lars Fruergaard Jørgensen, CEO of Novo Nordisk | Photo: Stine Bidstrup/ERH
Lars Fruergaard Jørgensen, CEO of Novo Nordisk | Photo: Stine Bidstrup/ERH
by marketwire, translated by daniel pedersen

Pharmaceutical firm Novo Nordisk’s sales growth has accelarated since 2019, when it introduced new financial targets and ambitions for 2025. A theme of the company’s capital markets day, which is taking place at the time of writing on Thursday, is how to continue on this track.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading